Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
Bain Capital is in talks to acquire Mitsubishi Chemical Group’s pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said.
Read more at The Wall Street Journal
Topics
-
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.CNBC - 8h -
Could Elon Musk buy Intel? As takeover talk swirls, one analyst is skeptical.
A Bernstein analyst recommends avoiding Intel’s stock as takeover rumors have the potential to drive a rally, though “it doesn’t feel like a long either.”MarketWatch - 10h -
Bid to restore ban on Bain & Co winning UK state contracts fails
Labour advised there are no legal grounds for reimposing restrictions on consultant that followed South African ‘misconduct’Financial Times - 16h -
Ernie Els wins season-opening Mitsubishi Electric Championship for 7th PGA Tour Champions title
Ernie Els won the season-opening Mitsubishi Electric Championship on Saturday for his seventh PGA Tour Champions victory, closing with a 6-under 66 to beat Bernard Langer, Miguel Angel Jimenez and ...ABC News - 3d -
Trump's Talk of Buying Greenland Energizes Island's Independence Movement
Many in the sprawling Danish territory don’t want to sell to the U.S., but they are open to the idea of a closer relationship.The Wall Street Journal - Jan. 11 -
Never Fear, the Mighty Mitsubishi Rally Support Kei Van Is Here
Yahoo News - Jan. 7 -
KKR urges Fuji Soft to take legal action against Bain in $4bn takeover fight
Public battle between private equity bidders for software company tests new ground in JapanFinancial Times - Jan. 7 -
MicroStrategy’s latest capital-raise plans are for $2 billion of preferred stock to buy more bitcoin
The move is part of the company’s plan to issue $21 billion of equity and $21 billion in fixed-income instruments over the next three years.MarketWatch - Jan. 6 -
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...The Hill - Jan. 2
More from The Wall Street Journal
-
Netflix Raises Prices Across Plans, Reports Record Jump in New Subscribers
The lowest-price, ad-supported option for the streaming service will cost $7.99 a month, an increase of $1.The Wall Street Journal - 5h -
Masimo Taps Katie Szyman as Permanent CEO
Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.The Wall Street Journal - 5h -
Basic Materials Roundup: Market Talk
Find insight on commodities prices, Press Metal Aluminium, BHP, Antofagasta and more in the latest Market Talks covering Basic Materials.The Wall Street Journal - 6h -
Auto & Transport Roundup: Market Talk
Read about North American auto production, Fraport, DHL Group and more in the latest Market Talks covering the Auto and Transport sector.The Wall Street Journal - 6h -
Financial Services Roundup: Market Talk
Find insight on carbon-credit markets, UniCredit, Standard Chartered and more in the latest Market Talks covering Financial Services.The Wall Street Journal - 6h
More in Business
-
SoftBank and OpenAI back sweeping AI infrastructure project in US
Donald Trump calls $100bn initiative a ‘declaration of confidence in America’Financial Times - 17m -
2 Families, in Business 50 Years, Fight for Control of Korea Zinc
Control of Korea Zinc, the world’s largest producer of zinc, is at stake in a battle challenging the country’s entrenched chaebol system of powerful conglomerates.The New York Times - 37m -
Trump says he's considering a 10% tariff on China beginning as soon as Feb. 1
On Tuesday, President Donald Trump floated a 10% duty on China, with an expected start date of Feb. 1.CNBC - 1h -
Tesla’s ‘Trump bump’ fades as stock falls alongside rest of EV sector
Investors still expect Musk to benefit more broadly from Trump 2.0.MarketWatch - 2h -
United Airlines stock rallies on results, as growing demand wasn’t just about premium seats
Shares of United Airlines rallied in after-hours trading Tuesday, as a record number of travelers lifted fourth-quarter results and the company offered an upbeat forecast for the first quarter.MarketWatch - 2h